1. In silico evaluation of pharmacokinetic parameters, delivery, distribution and anticoagulative effects of new 4,7-dihydroxycoumarin derivative.
- Author
-
Milanović Ž, Antonijević M, Avdović E, Simić V, Milošević M, Dolićanin Z, Kojić M, and Marković Z
- Subjects
- Humans, Warfarin chemistry, Warfarin pharmacology, Warfarin pharmacokinetics, Warfarin metabolism, Serum Albumin, Human chemistry, Serum Albumin, Human metabolism, Computer Simulation, Binding Sites, Vitamin K Epoxide Reductases chemistry, Vitamin K Epoxide Reductases metabolism, Vitamin K Epoxide Reductases antagonists & inhibitors, Anticoagulants chemistry, Anticoagulants pharmacology, Anticoagulants pharmacokinetics, Molecular Docking Simulation, Molecular Dynamics Simulation, Coumarins chemistry, Coumarins pharmacology, Protein Binding
- Abstract
In this study, pharmacological profiling and investigation of the anticoagulant activity of the newly synthesized coumarin derivative: ( E )-3-(1-((4-hydroxy-3-methoxyphenyl)amino)ethylidene)-2,4-dioxochroman-7-yl acetate ( L ) were performed. The obtained results were compared with the parameters obtained for Warfarin ( WF ), which is a standard good oral anticoagulant. The estimated high binding affinity of L toward plasma proteins (PPS% value is > 90%) justifies the investigation of binding affinity and comparative analysis of L and WF to Human Serum Albumin ( HSA ) using the spectrofluorimetric method (296, 303 and 310 K) as well as molecular docking and molecular dynamics simulations. Compound L shows a very good binding affinity especially to the active site of WF (the active site I -subdomain IIA), quenching HSA fluorescence by a static process. Also, the finite element smeared model (Kojic Transport Model, KTM), which includes blood vessels and tissue, was implemented to compute the convective-diffusion transport of L and WF within the liver. Finally, compound L shows a high degree of inhibitory activity toward the VKOR receptor comparable to the inhibitory activity of WF . Stabilization and limited flexibility of amino acid residues in the active site of the VKOR after binding of L and WF indicates a very good inhibitory potential of compound L . The high affinity of the L for the VKOR enzyme (Vitamin K antagonist), as well as the structural similarity to commercial anticoagulants ( WF ), provide a basis for further studies and potential application in the treatment of venous thrombosis, pulmonary embolism and ischemic heart disease.Communicated by Ramaswamy H. Sarma.
- Published
- 2024
- Full Text
- View/download PDF